These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34467650)

  • 1. Screening for depression in psoriasis patients during a dermatological consultation: A first step towards treatment.
    Kromer C; Mohr J; Celis D; Poortinga S; Gerdes S; Mössner R; Wilsmann-Theis D
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1451-1461. PubMed ID: 34467650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two questions may be enough - screening for depression in patients with psoriasis: a multicenter study.
    Gerdes S; Wilsmann-Theis D; Celis D; Kromer C; Mössner R
    J Dtsch Dermatol Ges; 2020 Oct; 18(10):1115-1125. PubMed ID: 32945601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms among mothers of children with psoriasis-A case-control study.
    Żychowska M
    Pediatr Dermatol; 2020 Nov; 37(6):1038-1043. PubMed ID: 33010067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity and management of psoriasis within primary care.
    Wade AG; Crawford GM; Young D; Leman J; Pumford N
    BMC Fam Pract; 2016 Oct; 17(1):145. PubMed ID: 27737638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of an Interdisciplinary Dermatological-Rheumatological Consultation on the Outcome of Patients with Psoriasis with Musculoskeletal Pain: A Prospective, Single-Center Cohort Study.
    von Ahnen JA; Gross G; Lull C; Blauth M; Kraemer B; Olsavszky V; Leipe J; Schmieder A
    Adv Ther; 2023 Dec; 40(12):5243-5253. PubMed ID: 37768507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
    J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial.
    Schmitt J; Wozel G; Garzarolli M; Viehweg A; Bauer M; Leopold K
    Acta Derm Venereol; 2014 Mar; 94(2):192-7. PubMed ID: 23995849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriatic patients: Analysis of patients dissatisfied with their management].
    Mahé E; Maccari F; Beauchet A; Quiles-Tsimaratos N; Beneton N; Parier J; Barthelemy H; Goujon-Henry C; Chaby G; Thomas-Beaulieu D; Géner G; Wagner L; Pallure V; Devaux S; Vermersch-Langlin A; Pfister P; Jégou J; Livideanu C; Sigal ML;
    Ann Dermatol Venereol; 2017; 144(8-9):497-507. PubMed ID: 28624255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study.
    Loft ND; Egeberg A; Rasmussen MK; Bryld LE; Gniadecki R; Dam TN; Iversen L; Skov L
    Acta Derm Venereol; 2019 Dec; 99(13):1224-1230. PubMed ID: 31580465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological burden of psoriatic patients in a German university hospital dermatology department.
    Sondermann W; Fiege O; Körber A; Scherbaum N
    J Dermatol; 2021 Jun; 48(6):794-806. PubMed ID: 33354818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice.
    Hölsken S; Krefting F; Schneider L; Benson S; Schedlowski M; Sondermann W
    J Dermatol; 2022 Mar; 49(3):341-348. PubMed ID: 34806209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and
    Kim SJ; Park MY; Pak K; Han J; Kim GW; Kim HS; Ko HC; Kim MB; Kim BS
    J Dermatolog Treat; 2018 Dec; 29(8):761-768. PubMed ID: 29658378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A
    J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile dysfunction in patients with psoriasis: potential impact of the metabolic syndrome.
    Tasliyurt T; Bilir Y; Sahin S; Seckin HY; Kaya SU; Sivgin H; Demir AK; Erdemir F
    Eur Rev Med Pharmacol Sci; 2014; 18(4):581-6. PubMed ID: 24610625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide risk and depression in patients with psoriasis.
    Bardazzi F; Bonci C; Sacchelli L; DI Altobrando A; Iommi M; Rucci P; Sacchelli P; Berardi D; Patrizi A; Tengattini V
    Ital J Dermatol Venerol; 2022 Dec; 157(6):497-501. PubMed ID: 36651203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation therapy in the management of psoriasis.
    Neerackal RJ; Abdul Latheef EN; Sukumarakurup S; Jafferany M
    Dermatol Ther; 2020 Nov; 33(6):e14030. PubMed ID: 32683732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.